SANDOZ INC.
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 24, 2017 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,352 Total Citation Count
- Mar 11, 1976 Earliest Filing
- 110 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
RE31061 5-Amino or substituted amino-7-phenyl or substituted phenyl-2,3-dihydro-1H-1,4-diazepinesMar 27, 80Oct 19, 82[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
4739073 Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereofExpiredMar 04, 85Apr 19, 88[C07D]
4686237 Erythro-(E)-7-[3'-C.sub.1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereofExpiredFeb 19, 86Aug 11, 87[A61K, C07D, C07C]
4673674 Diazepinoindoles useful for treating depression, schizophrenia, social withdrawal or anxiety and pharmaceutical compositions containing themExpiredFeb 21, 85Jun 16, 87[A61K, C07D]
4650890 Preparation of olefinic compounds and intermediates thereofExpiredJul 26, 85Mar 17, 87[C07C, C07B]
4625039 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediatesExpiredDec 21, 83Nov 25, 86[C07D]
4613610 Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivativesExpiredJun 06, 85Sep 23, 86[A61K, C07D]
4582848 2-substituted-3-indolamines and use thereof as anti-diabeticsExpiredJun 16, 83Apr 15, 86[A61K, C07D]
4551288 Processes for the preparation of liposome drug delivery systemsExpiredSep 07, 84Nov 05, 85[A61K, B01J]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.